Helix BioPharma Corp.
General ticker "HBPCF" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $8.4M (TTM average)
Helix BioPharma Corp. follows the US Stock Market performance with the rate: 30.5%.
Estimated limits based on current volatility of 0.0%: low 1.73$, high 1.73$
Factors to consider:
- Earnings for 15 months up through Q1 (+1 year) exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-07-31 to 2026-07-31
- 2024-07-31 to 2025-07-31 estimated range: [0.49$, 1.19$]
- 2025-07-31 to 2026-07-31 estimated range: [0.42$, 1.04$]
Financial Metrics affecting the HBPCF estimates:
- Positive: with PPE of -6.0 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -4.09 <= 0.33
- Negative: negative Industry operating cash flow (median)
- Positive: -2.95 < Return on assets ratio (scaled to [-100,100]) of -0.62
- Positive: Inventory ratio change, % of 0 <= 0
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Negative: Shareholder equity ratio, % of -6.04 <= 18.93
Short-term HBPCF quotes
Long-term HBPCF plot with estimates
Financial data
| YTD | 2023-07-31 | 2024-07-31 |
|---|---|---|
| Operating Revenue | CA$0.00MM | CA$0.00MM |
| Operating Expenses | CA$6.33MM | CA$0.01MM |
| Operating Income | CA$-6.33MM | CA$-0.01MM |
| Non-Operating Income | CA$0.04MM | CA$0.00MM |
| Interest Expense | CA$0.01MM | CA$0.00MM |
| R&D Expense | CA$5.34MM | CA$0.01MM |
| Income(Loss) | CA$-6.29MM | CA$-0.01MM |
| Profit(Loss)* | CA$-6.29MM | CA$9.25MM |
| Stockholders Equity | CA$-0.84MM | CA$-0.09MM |
| Assets | CA$1.03MM | CA$1.49MM |
| Operating Cash Flow | CA$-5.53MM | CA$-5.22MM |
| Capital expenditure | CA$0.01MM | CA$0.01MM |
| Investing Cash Flow | CA$-0.01MM | CA$-0.01MM |
| Financing Cash Flow | CA$3.09MM | CA$5.51MM |
| Earnings Per Share** | CA$-0.03 | CA$0.08 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.